Clinical trial
Recombinant Hyaluronidase in Out-of-Hospital Setting: The EASI Access Trial
NCT00386386 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00386386 |
|---|---|
| Title | Recombinant Hyaluronidase in Out-of-Hospital Setting: The EASI Access Trial |
| Official title | Enzymatically Augmented Subcutaneous Infusion (EASI) In Out-Of-Hospital Care |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Baxter Healthcare Corporation Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mass Casualty Incident, Dehydration |
| Intervention type | Other |
| Interventions | hypodermoclysis via recombinant hyaluronidase-facilitated subcutaneous infusion |
| Enrollment | 20 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Oct 11, 2006 |
| Last update posted | Mar 13, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: